trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

NSAIDs, including ibuprofen, can cause serious gastrointestinal adverse events such as inflammation, bleeding, ulceration, and perforation of the stomach or intestines.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that NSAIDs, including ibuprofen, can cause serious gastrointestinal adverse events such as inflammation, bleeding, ulceration, and perforation of the stomach or intestines?

Yes. Nonsteroidal anti-inflammatory drugs, including ibuprofen, are well-documented to cause serious upper and lower gastrointestinal complications, such as mucosal inflammation, bleeding, and peptic ulceration.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently support the well-established medical consensus that NSAID use causes serious gastrointestinal adverse events, including bleeding, inflammation, and ulceration. Multiple studies explicitly discuss NSAID-induced ulcers, mucosal damage, and gastrointestinal bleeding risks, supporting the claim without any refuting evidence.

Evidence for · 7
2019
Identifies older adults taking nonsteroidal anti-inflammatory drugs (NSAIDs) as having an increased risk of gastrointestinal bleeding.
Get citation
McDonald, D. D. (2019). Predictors of gastrointestinal bleeding in older persons taking nonsteroidal anti-inflammatory drugs: Results from the FDA adverse events reporting system. doi.org. https://doi.org/10.1097/jxx.0000000000000130

See more details
More for · 6
2024
Discusses the gastrointestinal mucosal damage and ulcerations associated with oral non-steroidal anti-inflammatory drugs.
Get citation
H, F., S, F., T, Y., T, M., T, T., K, O., Y, T., & T, M. (2024). Investigation of the effects of a new transdermal formulation of systemic diclofenac on the upper gastrointestinal mucosa in patients with low back pain: A comparative study with oral diclofenac.. doi.org. https://doi.org/10.1111/jgh.16810

2026
Evaluates treatments for the prevention of peptic ulcers induced by long-term nonsteroidal anti-inflammatory drug therapy.
Get citation
SG, K., TO, K., SW, J., BH, M., JH, O., HS, K., GH, L., JH, S., IK, S., YS, C., SC, C., YJ, L., BW, K., CM, S., CW, H., JW, K., KO, K., YK, C., OY, L., JS, M., HW, L., HY, J., WG, S., JG, K., JY, L., SJ, H., SW, K., JH, C., H, L., TH, K., MI, P., GH, B., RR, C., SK, L., & JJ, K. (2026). A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory Drugs.. doi.org. https://doi.org/10.5009/gnl260057

2025
Highlights the gastrointestinal adverse effects of NSAIDs and discusses management strategies such as discontinuation or prophylaxis.
Get citation
F, A., MM, A., E, A. J., Z, A., & A, A. J. (2025). Physicians' attitudes toward gastroprotective strategies for nonsteroidal anti-inflammatory drug prescription.. doi.org. https://doi.org/10.1080/08998280.2024.2418779

2026
Notes that nonsteroidal anti-inflammatory drugs are a major contributor to upper gastrointestinal bleeding and peptic ulcers alongside other agents.
Get citation
H, L., JW, C., KO, K., KA, K., & JH, K. (2026). Pharmacological Management of Peptic Ulcer Bleeding.. doi.org. https://doi.org/10.7704/kjhugr.2025.0075

2026
Lists the use of nonsteroidal anti-inflammatory drugs as a well-established risk factor for gastrointestinal bleeding.
Get citation
N, D., L, A., LC, B., RA, S., C, P., MO, B., BS, T., BȘ, P., & C, S. (2026). Prevention of Gastrointestinal Bleeding in Patients Receiving Direct Oral Anticoagulants: A Narrative Review and Practical Framework for Prescribers.. doi.org. https://doi.org/10.3390/clinpract16070120

2026
Outlines clinical guidelines and management strategies for drug-induced ulcers caused by nonsteroidal anti-inflammatory drugs.
Get citation
M, S., T, K., M, I., J, I., T, O., S, O., T, K., T, C., K, T., S, N., T, M., T, W., D, A., E, I., T, W., H, O., R, K., S, K., N, K., S, S., A, S., H, S., H, C., D, C., O, D., A, N., A, H., Y, H., K, M., K, M., D, M., J, M., H, M., S, Y., J, W., K, S., Y, M., A, T., Y, T., S, E., S, W., H, I., T, I., & S, M. (2026). Evidence-based clinical practice guidelines for peptic ulcer disease 2026.. doi.org. https://doi.org/10.1007/s00535-026-02504-3

What does the evidence say?

The retrieved papers consistently support the well-established medical consensus that NSAID use causes serious gastrointestinal adverse events, including bleeding, inflammation, and ulceration. Multiple studies explicitly discuss NSAID-induced ulcers, mucosal damage, and gastrointestinal bleeding risks, supporting the claim without any refuting evidence.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work